1. Expression of Livin and PlGF in human osteosarcoma is associated with tumor progression and clinical outcome
   Kuo Sun et al, 2018, Oncology Letters CrossRef
2. Meta-analysis showing that ERCC1 polymorphism is predictive of osteosarcoma prognosis
   Xueyong Liu et al, 2017, Oncotarget CrossRef
3. Establishment and characterization of novel patient-derived osteosarcoma xenograft and cell line
   Fusako Kito et al, 2018, In Vitro Cellular & Developmental Biology - Animal CrossRef
4. Functional variant of IL33 is associated with survival of osteosarcoma patients
   Qingxi Lin et al, 2020, Journal of Bone Oncology CrossRef
5. Vascular endothelial growth factor A (VEGFA) promoter rs2010963 polymorphism and cancer risk: An updated meta-analysis and trial sequential analysis
   Md. Abdul Aziz et al, 2022, Meta Gene CrossRef
6. Genetic variants associated with osteosarcoma risk: a systematic review and meta-analysis
   Omneya Hassanain et al, 2024, Scientific Reports CrossRef
7. Vascular endothelial growth factor polymorphisms are associated with osteosarcoma susceptibility
   Yuan-Yuan Hu et al, 2016, Oncotarget CrossRef
8. Epidemiological Evidence for Associations Between Genetic Variants and Osteosarcoma Susceptibility: A Meta-Analysis
   Dechao Yuan et al, 2022, Frontiers in Oncology CrossRef